Public annual accounts

Dr. Isabel Poppe financials

Name: Dr. Isabel Poppe financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Isabel Poppe, with comparable measures and links to available source documents.

Company overview

Registry number

0664705366

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Dr. Isabel Poppe

2025 versus 2024

Operating line: €165,112
EBITDA: €164,369
Total assets: €420,874
Equity: €413,827

EBITDA margin +99.6% · Equity ratio +98.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€165,112	€164,369	€420,874	€413,827	-
202431 Dec 2024	€153,149	€152,396	€313,829	€294,285	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report